skip nav
National Prevention Information Network
Search Help
Other Searches: Search Organizations | Search Materials | Search Campaign Resources | Search Funding
español
Share Share this page on Twitter Share this page on Facebook Share this page on LinkedIn View more options to share this page E-mail this page to a colleague Print this page


<< Back

Funding

Integrated Preclinical/Clinical Program for HIV Microbicides and Biomedical Prevention (IPCP-MBP) (U19)

Description
Grant Amount: NIAID intends to commit $9.1 million yearly for 1 to 3 awards.

The National Institute of Allergy and Infectious Diseases (NIAID) invites applications from single institutions and consortia of institutions to participate in the Integrated Preclinical/Clinical Program for HIV Microbicides and Biomedical Prevention (IPCP-MBP). The purpose of this FOA is to support integrated and iterative multi-project, multi-disciplinary preclinical development efforts and exploratory clinical studies with the goal of advancing, strengthening and maintaining an innovative pipeline of non-vaccine biomedical prevention (nBP) strategies, including microbicides, PrEP, and Multipurpose Prevention Technologies (MPT). The purpose of the multi-project and core environment of the IPCP-MBP is to stimulate and support a strong, diverse base in preclinical discovery and development of nBP candidates that includes development of single and combination nBP delivered to the male and female genital and gastrointestinal (GI) tracts to prevent HIV acquisition/transmission. The purpose will be accomplished by supporting the translation of candidates and strategies from preclinical to pre-Phase I clinical studies delivered by a variety of drug delivery systems (DDS), including gels, films, quick dissolving tablets, intravaginal rings (IVR), implants, oral, injection and MPT-based DDS strategies. A minimum of two research projects and an Administrative Core must be proposed. At least one component (research project or Scientific Core) must be from a private sector for-profit or not-for-profit company. The proposed research is not required to include a pre-Phase I clinical trial or provide comprehensive coverage for all activities that might be required to develop a specific candidate or strategy for advancement to clinical trials.

NOTE: While pre-Phase I clinical trials conducted within the continental United States (U.S.) are responsive, Pre-Phase I clinical trials proposed to be conducted at non-U.S. sites will not be supported under this FOA. This FOA will not support any clinical trials (Phase I, II or III) that do not meet the definition of a pre-Phase I clinical trial. Applicants are encouraged to seek other sources of support for traditional Phase I, II, or III clinical trials and the production of drug substance and products required to support them.

Funding Organization
National Institute of Allergy and Infectious Diseases
Division of Intramural Research
Fund Category
HIV/AIDS
Support Types
Cooperative Agreements
Locations
International
National
Eligible Organizations
City Agencies
Colleges/Universities
Commercial Organizations
Community Based Organizations
County Agencies
Educational Organizations/Institutions
Federal Government Agencies
International Agencies
IRS 501 (c)(3) Organizations
Nonprofit Organizations
Religious Organizations
Schools
State Agencies
Tribal Organizations
Number of Awards Given
1 to 3 awards
Award Amount Notes
NIAID intends to commit $9.1 million yearly for 1 to 3 awards.
Letter of Intent Date
10/13/2013
Application Due Date
11/13/2013
Project Start Date
7/1/2014
Application Contact
GrantsInfo
,
Phone: (301) 435-0714
Technical Contact
Jim A Turpin
NIAID
Phone: (301) 451-2732
Fund Duration
An applicant may request a project period of up to 4 years for an application that does not include a pre-Phase I clinical trial, and up to 5 years for an application that includes a pre-Phase I clinical trial.
Subjects
Clinical Research
Clinical Trials
HIV/AIDS Prevention
Audiences
Researchers
Application Process
Applicants can access the SF424 (R&R) application package associated with this funding opportunity using the “Apply for Grant Electronically” button in this FOA or following the directions provided at Grants.gov.

It is critical that applicants follow the instructions in the SF424 (R&R) Application Guide (http://grants.nih.gov/grants/funding/424/SF424_RR_Guide_General_Adobe_VerB.pdf), except where instructed in this funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.
Web Site
http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-13-023.html
Fund Number
RFA-AI-13-023

Disclaimer: NPIN provides this information as a public service only. The views and information provided about the materials, funding opportunities, and organizations do not necessarily state or reflect those of the U.S. Department of Health and Human Services, CDC, or NPIN.

cdcnpin.org Fund Record #4731

<< Back

CDCNPIN.org

Contact Us
About Us
HIV Content Notice
Privacy Policy
Policies & Disclaimers
Site Index
Help Using the CDC NPIN Web Site

CDC NPIN Searches

Search Organizations
Search Materials
Search Funding Opportunities
Search Campaign Resources
Help Using the CDC NPIN Searches

CDC NPIN Resources

hivtest.cdc.gov
m.hivtest.cdc.gov
findtbresources.org
STD Awareness Microsite
findstdtest.org
AIDS Gov Logo and Link CDC Logo and Link